
GLP-1 agonists – too good to be true?
By Juliette Martin, Nutritional Therapist: Over the past year, a family of medications called GLP-1 agonists, often referred to as the ‘skinny jab’ has captured widespread media attention.
Providing independent clinical excellence since 2005
Posted on Tuesday March 5, 2024 in Naked Heart
I An article by Dr Edward Leatham, Consultant Cardiologist, author of The Naked Heart a series of simple blog and video explanations covering all of the main common medical conditions that can affect us, as we age.
Atrial fibrillation, commonly referred to as AFib, is a cardiovascular condition that manifests in various ways, significantly influenced by how the atrial rate is moderated by the atrioventricular node and, to some extent, the individual’s perception of their heart rhythm. This atrial impulses typically revolves around 600 cycles per minute. Understanding the factors that dictate its clinical presentation is important for timely diagnosis and management, given the condition’s potential to cause severe complications like stroke and heart attacks.
Many individuals with atrial fibrillation, especially those who experience lower pulse rates while in this state, might not even be aware that they have the condition. This lack of awareness is concerning, as it elevates the risk of stroke. Blood clots can begin to form within the left atrium if atrial fibrillation persists for more than 24 hours, posing a significant risk.
During atrial fibrillation, the left atrium exhibits uncoordinated movements, but the primary concern is the left atrial appendage, a small extension of the left atrium. Even under normal conditions, this area experiences reduced blood movement, which worsens during fibrillation. The resultant stasis in the left atrium, particularly in the appendage, is where blood clots typically originate. Upon the restoration of normal sinus rhythm, these clots can detach and enter the bloodstream, leading to embolization in critical arteries.
When clots from the left atrial appendage dislodge, they can travel to various parts of the body, including the coronary artery, which receives about 5% of the blood from each heartbeat, or the cerebral arteries, accounting for approximately 20% of each cardiac cycle’s output. The location where a clot lodges can have significant implications. If a clot obstructs the coronary arteries or cerebral arteries, it can lead to catastrophic outcomes like heart attacks or strokes, respectively, drastically affecting the individual’s quality of life and requiring urgent medical intervention.
Given the severe repercussions of atrial fibrillation, it’s imperative for individuals, especially those at risk, to undergo regular monitoring for early detection. Healthcare providers play a critical role in educating patients about the potential symptoms and the importance of timely medical consultation if they suspect something is amiss. Effective management strategies, including medication, lifestyle changes, and possibly surgical interventions, are essential to mitigate the risks associated with this condition.
In conclusion, atrial fibrillation is a complex cardiovascular disorder with varied presentations and significant risks. Its management is pivotal in preventing severe outcomes like strokes and heart attacks. Through awareness, early detection, and proactive treatment, the dangers associated with atrial fibrillation can be significantly reduced, enhancing patient outcomes and quality of life.
If you would like to receive notifications as new stories are released, please join the Naked Heart mailing List